Success Metrics

Clinical Success Rate

100.0%

Based on 1 completed trials

Completion Rate

100%(1/1)

Active Trials

2(50%)

Results Posted

0%(0 trials)

Phase Distribution

Ph not_applicable

100%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

N/ANon-phased studies

4(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(2)

Completed(1)

Terminated(1)

Detailed Status

Recruiting1

Active, not recruiting1

Completed1

Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

N/A

Trials by Phase

N/A4 (100.0%)

Trials by Status

recruiting125%

active_not_recruiting125%

completed125%

withdrawn125%

Recent Activity

2 active trials

Showing 4 of 4

recruitingnot_applicable

Feasibility Study of the Supira System in Patients Undergoing HRPCI With Support Beyond the PCI Procedure

NCT07407816

withdrawnnot_applicable

A Safety and Effectiveness Study of the Supira System in Patients Undergoing HRPCI - CE Study

NCT06565039

completednot_applicable

Early Feasibility Study of the Supira System in Patients Undergoing HRPCI

NCT06087575

active_not_recruitingnot_applicable

Feasibility Study SA of the Supira System for HRPCI

NCT05864248

Clinical Trials (4)

Showing 4 of 4 trials

NCT07407816Not Applicable

Feasibility Study of the Supira System in Patients Undergoing HRPCI With Support Beyond the PCI Procedure

Recruiting

NCT06565039Not Applicable

A Safety and Effectiveness Study of the Supira System in Patients Undergoing HRPCI - CE Study

Withdrawn

NCT06087575Not Applicable

Early Feasibility Study of the Supira System in Patients Undergoing HRPCI

Completed

NCT05864248Not Applicable

Feasibility Study SA of the Supira System for HRPCI

Active Not Recruiting

All 4 trials loaded

Drug Details

Intervention Type: DEVICE
Total Trials: 4